943924-39-8Relevant articles and documents
Macrocyclic BACE-1 inhibitors acutely reduce Aβ in brain after po application
Lerchner, Andreas,Machauer, Rainer,Betschart, Claudia,Veenstra, Siem,Rueeger, Heinrich,McCarthy, Clive,Tintelnot-Blomley, Marina,Jaton, Anne-Lise,Rabe, Sabine,Desrayaud, Sandrine,Enz, Albert,Staufenbiel, Matthias,Paganetti, Paolo,Rondeau, Jean-Michel,Neumann, Ulf
scheme or table, p. 603 - 607 (2010/06/19)
A series of macrocyclic peptidic BACE-1 inhibitors was designed. While potency on BACE-1 was rather high, the first set of compounds showed poor brain permeation and high efflux in the MDRI-MDCK assay. The replacement of the secondary benzylamino group wi
MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS
-
Page/Page column 32, (2008/06/13)
The invention relates to novel macrocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.